Resource

A Conversation with Dr. Elin Haf Davies of Aparito

The rare disease space presents numerous challenges for clinical research and patient data capture. These challenges are only heightened for younger patient populations, where outcome measures and dosages need to be considered appropriately. Join Dr. Elin Haf Davies, Founder & CEO of Aparito, in conversation with Mark Wade, Global Practice Leader at TransPerfect Life Sciences, as they discuss: - The disparity in data capture for pediatric populations. - Considerations...

Resource

LifeSci Talks COA Series | Harnessing Implementation Science to Improve Health Outcomes: Methods and Approaches for the Future

Implementation science emerged as a response to the recognition that many effective health interventions and innovations were not being widely adopted or sustained in practice, even when evidence of their efficacy was strong. Join Meredith Smith, Senior Director of Implementation Science of Evidera in conversation with Mark Wade, Global Practice Leader of TransPerfect Life Sciences, as they explore the field of implementation science and its role in improving the translation...

Resource

Intelligent Automation for MDR & IVDR Content: Summary of Safety & Clinical Performance (SSCP), Summary of Performance (SSP), and Selected Labeling

Content requirements under the EU’s MDR and IVDR, including the translation of labeling, marketing, SSCPs, SSPs, and clinical communications, are set to dramatically increase. Currently, most device manufacturers use manual processes and document-based applications like Microsoft Word and InDesign to manage their content. However, manual processes and document-based approaches require additional headcount to handle increased volumes and faster turnarounds. Download our paper...

Resource

EU CTR White Paper - Operational Considerations & Challenges

The Clinical Trial Regulation (EU) 536/2014 (CTR) came into effect on January 31, 2022, replacing the previous regulatory framework of the Clinical Trial Directive 2001/20/EC (CTD). This white paper provides an overview of the CTR and its impact on the organizational readiness and operational execution of clinical trials in the European Union (EU) and European Economic Area (EEA) Member States. Discover the main features of the CTR, including the use of the "Regulation...

Event

Mastering Inspector Access: Streamlining Regulatory Reviews

Regulatory inspections can be complex and demanding, but a well-prepared Trial Master File (TMF) can significantly ease the process. Ensuring seamless inspector access, optimizing TMF quality review workflows, and maintaining compliance with regulatory expectations are critical for a successful inspection. In this webinar, industry experts Laurel-Ann Schrader and Ben Rogers will provide practical strategies to enhance TMF accessibility while maintaining security and...

Resource

LifeSci Talks COA Series | Exploring the Value Add of In-Study Interviews as a Critical COA Endpoint

In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Tom Willgoss, Patient-Centered Outcomes Research Chapter Lead, UK Site Head for Data Sciences at Roche to discuss the value of understanding and measuring patient experience data throughout the clinical journey. They delve into the significance of patient-centered clinical outcome assessments for endpoint selection in clinical trials, prioritizing...

Resource

LifeSci Talks COA Series | Breaking the Hype Cycle: An Objective Look at Remote Research Strategies in DCTs

In the first part of TransPerfect's latest LifeSci Talks episode, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, with guest Dr. Michelle Longmire, CEO of Medable, spoke about how a Stanford doctor transitioned into a career of entrepreneurship, creating a multimillion dollar eClinical company. Continuing the conversation in part two, the pair explore the commercial aspects of e-clinical solutions, particularly focusing on the landscape of Decentralized...

Resource

Digital Health Global Expansion Roadmap

For digital health companies—whether startups or tech giants—successfully launching new digital health apps starts with user adoption. To ensure long-term sustainability, these apps must attract, engage, and retain a diverse user base, which means they need to be culturally and linguistically accessible to a global audience. ...

Resource

RAPS Conference Takeaways

The Quick Conference Catch Up is a device industry reporting service from TransPerfect Medical Device. Based on live attendance at premier regulatory and strategy conferences, each Catch Up uses a conversational format to recap and highlight key conference takeaways. In these short video summaries, you will find insights on headline device industry issues, while saving the time and expense of in-person attendance!...

Resource

The Total Economic Impact of TransPerfect GlobalLink for Life Sciences

TransPerfect commissioned Forrester Consulting to conduct a Total Economic Impact™ (TEI) study and examine the return on investment (ROI) enterprises may realize by deploying GlobalLink. The objective of the framework is to identify the cost, benefit, flexibility, and risk factors that affect the investment decision. Forrester took a multistep approach to evaluate the impact that GlobalLink can have on an organization. The purpose of this study is to provide readers with a...

Resource

LifeSci Talks COA Series | Making the Most of Smaller Population Samples: Qualitative Insights in Rare Disease

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr. Kate Williams, Director of Patient-Centred Outcomes Research at Acaster Lloyd, to explore the nuances of gathering and applying qualitative data in rare disease research. From intaking both the patient and caregiver experience using a narrative approach, to qualitatively describing the experience of living in different disease states, the two focus on the...

Resource

Rewriting the Rules of Informed Consent Development with AI

Regardless of the market a clinical trial is being conducted in, getting locally approved informed consent forms (ICFs) consume as much as 12% of a clinical trial budget before it even begins. Each ICF must be clear and delicately balance local regulations and patient understanding while meeting strict deadlines. From analyzing the current landscape to identifying the opportunities AI presents, TransPerfect’s regulatory, medical writing, and content technology experts will...

Resource

Web Localization Playbook for Life Sciences

The life sciences industry relies on websites to connect with patients, sites, and global audiences. Whether you're launching a patient recruitment campaign or managing an international healthcare marketing initiative, localization ensures your message is not just understood: it's trusted, actionable, and compliant. In this downloadable playbook, learn more about effective web localization and the technologies will power it in 2025 and beyond. ...

Resource

LifeSci Talks COA Series | Balancing Innovation and Integrity: AI’s Place in Patient-Focused Research

Artificial intelligence is redefining what’s possible across the clinical development lifecycle, but with rapid innovation comes the need for thoughtful oversight. In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Richard “RJ” Kedziora, Co-Founder of Estenda Solutions, to explore how AI is transforming clinical research and digital health. From scaling informed consent through digital avatars to detecting patient...

Resource

LifeSci Talks COA Series | Modernizing eCOA: Emulators, Backups, and the Future of Reporting

In this tech-forward episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, welcomes Indira Jain-Figueroa, Product Director at Evinova, for a deep dive into the ever-evolving landscape of eCOA development. Covering everything from cross-platform development, backups, and emulator use to the future role of AI in reporting, this conversation highlights how innovation can improve both user experience and study efficiency in clinical trials....

Resource

Improving Learning Outcomes in Life Sciences Through Data-Driven Benchmarking

In life sciences, strong training programs are essential, but knowing whether they’re actually effective can be a difficult endeavor. In this session, Amanda Hernandez, Director of Sales Training & Effectiveness and Barrett Gaylord, Sales Training Lead of Telix Pharmaceuticals alongside Jessica Peyser, Senior Director at TransPerfect Life Sciences, discuss practical ways to benchmark training performance to help teams see where their programs are meeting performance...

Resource

Fast, Compliant, Centralized Translation in Action: Lessons from AbbVie & Immunovant

Due to high interest following our GlobalLink NEXT panel, we’re welcoming back Stacey Higgins, Associate Director, COA & Digital Implementation Team of AbbVie alongside Tihirah Harris, Sr Manager, Clinical Business Operations of Immunovant to share how and why they moved to a centralized, tech-enabled translation model—enabling faster trial timelines, cost control, and regulator-ready content. We'll also cover what’s ahead on their centralization roadmap, including...

Resource

Transforming Medical Affairs Practices with AI and Automation for Scalable Impact

Life sciences organizations are turning to AI to enhance operational efficiency, and one of the hottest areas of interest is the integration of AI and automation for medical affairs workflows. Beyond process optimization, automation has been accelerating omnichannel strategies by enabling and improving precise, personalized, and scaled communications with patients and healthcare professionals. As a key strategic partner to many parts of an organization, medical affairs...

Resource

GenAI Strategies for Life Sciences: Creating Content that Performs, Complies, and Resonates

Everyone’s talking about GenAI, but what does it really mean for pharma communications and promotional materials? Join our life sciences and AI experts in a follow up session from Search, Reinvented Evolving SEO in the Era of LLMs and GenAI, where we’ll take a closer look into how large language models are changing how we create and find content. This session will cover what effective SEO looks like today and how to create content that not only ranks but resonates,...

Resource

LifeSci Talks COA Series | Silver Bullet or Useful Repositories: The Reality of Clinical Trial Libraries

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, is joined by Jonathan Norman, Director of Translation and Localization at YPrime, for an in-depth discussion on the realities of eCOA libraries. Together, they explore why “libraries” are more accurately described as asset repositories, the conditions under which reuse can meaningfully accelerate study timelines, and the limitations that prevent them from being a universal...

Resource

Integrating eCOAs and Digital Health Technologies for Patient-Centric Trials

The foundation of patient-first design is technology that connects seamlessly to support and meet patients where they are. In this session, leaders from Pfizer, THREAD, Datacubed, Obvio Health, and Merative will discuss how integrated digital ecosystems are breaking down platform and industry silos, enhancing engagement, improving access, and scaling across therapeutic areas. Learn how pharma and tech companies are expanding digital endpoints and paving the way for the next...

Resource

Digital Transformation Fireside Chat

In this fireside chat, Christine Buggle-Spearing and Dr. Gigi Shafai, Pharm.D., from TransPerfect Life Sciences, share practical strategies for modernizing medical affairs processes. The discussion covers how to design a digital-first strategy that creates value for both patients and organizations, use digital platforms to enhance collaboration with healthcare professionals and patients, and prepare teams for the evolving impact of AI on the medical affairs landscape....